Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.
2.

Increase in plasmacytoid and myeloid dendritic cells by progenipoietin-1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-Infected rhesus macaques.

Koopman G, Niphuis H, Haaksma AG, Farese AM, Casey DB, Kahn LE, Mann D, MacVittie TJ, Woulfe SL, Heeney JL.

Hum Immunol. 2004 Apr;65(4):303-16.

PMID:
15120185
3.

A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.

Pullarkat V, Lee PP, Scotland R, Rubio V, Groshen S, Gee C, Lau R, Snively J, Sian S, Woulfe SL, Wolfe RA, Weber JS.

Clin Cancer Res. 2003 Apr;9(4):1301-12.

4.

Characterization of dendritic cells generated in vivo by an E. coli derived chimeric dual receptor agonist.

Kahn LE, Doshi PD, McGarity KL, Yu M, Bono CP, Lie WR, Rankin AM, Smidt ML, Streeter PR, Klein BK, Welply JK, Woulfe SL.

Med Sci Monit. 2002 Dec;8(12):BR504-14.

PMID:
12503028
5.

Mobilization of dendritic cells in cancer patients treated with granulocyte colony-stimulating factor and chemotherapy.

Radcliff FJ, Caruso DA, Koina C, Riordan MJ, Roberts AW, Tang ML, Baum CM, Woulfe SL, Ashley DM.

Br J Haematol. 2002 Oct;119(1):204-11.

PMID:
12358927
6.

Progenipoietin-generated dendritic cells exhibit anti-tumor efficacy in a therapeutic murine tumor model.

Björck P, Lie WR, Woulfe SL, Klein BK, Olson W, Storkus WJ.

Int J Cancer. 2002 Aug 10;100(5):586-91.

7.

Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function.

Ishioka GY, Fikes J, Qin M, Gianfrani C, Chesnut RW, Kahn LE, Streeter PR, Woulfe SL, Sette A.

Vaccine. 2001 Jun 14;19(27):3710-9.

PMID:
11395205
8.

Progenipoietins: biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor.

Streeter PR, Minster NI, Kahn LE, Hood WF, Vickery LE, Thurman TL, Monahan JB, Welply JK, McKearn JP, Woulfe SL.

Exp Hematol. 2001 Jan;29(1):41-50.

PMID:
11164104
9.

The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis.

Chauhan B, Santiago L, Kirschmann DA, Hauptfeld V, Knutsen AP, Hutcheson PS, Woulfe SL, Slavin RG, Schwartz HJ, Bellone CJ.

J Immunol. 1997 Oct 15;159(8):4072-6.

PMID:
9378997
10.

A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation.

Woulfe SL, Bono CP, Zacheis ML, Welply JK, Kirschmann DA, Baudino TA, Wang Y, Stone DA, Hanson GJ, Vuletich JL, Bedell LJ, Schwartz BD, Howard SC.

J Pharmacol Exp Ther. 1997 May;281(2):663-9.

PMID:
9152371
11.

Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.

Kirschmann DA, Duffin KL, Smith CE, Welply JK, Howard SC, Schwartz BD, Woulfe SL.

J Immunol. 1995 Dec 15;155(12):5655-62.

PMID:
7499850
12.

Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401.

Woulfe SL, Bono CP, Zacheis ML, Kirschmann DA, Baudino TA, Swearingen C, Karr RW, Schwartz BD.

Arthritis Rheum. 1995 Dec;38(12):1744-53.

PMID:
8849346
13.

Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.

Fu XT, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, Sette A, Schwartz BD, Karr RW.

J Exp Med. 1995 Mar 1;181(3):915-26.

14.

Utilization of soluble fusion proteins for induction of T cell proliferation.

Kirschmann DA, De Ciechi PA, Bono CP, Zacheis ML, Schwartz BD, Woulfe SL.

Cell Immunol. 1995 Feb;160(2):193-8.

PMID:
7720079
15.

Characterization of a DNA-binding protein system which is inversely correlated with class II expression.

Didier DK, Woulfe SL, Schwartz BD.

Immunol Res. 1990;9(1):69-76. Review. No abstract available.

PMID:
2406353
16.

Evidence for heterogeneity of the DPA and DPB alleles derived from a DRw11,DQw7,DPw4 cell line.

Woulfe SL, Rice K, Didier DK, Harris MR, Schiffenbauer J, Klearman M, Farrar MA, Schwartz BD.

Hum Immunol. 1989 Sep;26(1):39-45.

PMID:
2777643
17.

A unique sequence of the NZW I-E beta chain and its possible contribution to autoimmunity in the (NZB x NZW)F1 mouse.

Schiffenbauer J, McCarthy DM, Nygard NR, Woulfe SL, Didier DK, Schwartz BD.

J Exp Med. 1989 Sep 1;170(3):971-84.

18.

Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box.

Didier DK, Schiffenbauer J, Woulfe SL, Zacheis M, Schwartz BD.

Proc Natl Acad Sci U S A. 1988 Oct;85(19):7322-6.

Supplemental Content

Loading ...
Support Center